NK cells to cure cancer

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Natural Killer (NK) cells are crucial innate lymphocytes for immune surveillance against viral infections and transformed cells.
• NK cells exhibit a complex role in cancer, potentially inhibiting or promoting tumor progression and immune suppression.
• Tumor escape mechanisms involve aberrant NK cell receptor expression, impaired migration, and reduced effector functions.

Purpose of the Study:

• To review current understanding of NK cell receptors and molecules as prognostic factors and therapeutic targets.
• To discuss advances in genetically modified and expanded NK cells for adoptive cellular transfer therapies.
• To highlight strategies for unleashing NK cell anti-tumor effector functions.

Main Methods:

• Literature review of experimental and clinical evidence on NK cell biology in cancer.
• Analysis of current clinical applications of NK cell receptors and related molecules.
• Overview of recent developments in NK cell genetic modification and ex vivo expansion.

Main Results:

• NK cell immune checkpoints and their aberrant expression are key mechanisms of tumor escape.
• NK cell receptors and associated molecules are emerging as prognostic indicators and therapeutic targets.
• Genetic modification and ex vivo expansion are advancing adoptive NK cell therapies.

Conclusions:

• Targeting NK cell immune checkpoints and enhancing their effector functions are promising strategies for cancer immunotherapy.
• Adoptive transfer of engineered NK cells represents an innovative therapeutic approach for cancer treatment.
• Further research into NK cell biology and therapeutic manipulation is essential for improving cancer outcomes.